Trademark: 87274467
Word
BIOHM
Status
Registered
Status Code
700
Status Date
Tuesday, July 31, 2018
Serial Number
87274467
Registration Number
5531063
Registration Date
Tuesday, July 31, 2018
Mark Type
4000
Filing Date
Tuesday, December 20, 2016
Published for Opposition
Tuesday, March 6, 2018

Trademark Owner History

Classifications
5 Probiotic supplements; vitamin and mineral supplements; vitamin supplements; whey protein supplements; dietary supplement drink mixes; dietary supplement for eliminating toxins from the intestinal tract; enzyme food supplements; herbal supplements; mineral supplements; multi-vitamin preparations; natural herbal supplements; nutraceuticals for use as a dietary supplement; nutritional supplement for eliminating toxins from the intestinal tract; nutritional supplement shakes; nutritional supplements, namely, probiotic compositions; nutritional supplements, namely, carbohydrates in powdered form; powdered nutritional supplement concentrate; vitamin and mineral supplements in powder, tablet, liquid, capsule or spray form; mineral supplements in powder, tablet, liquid, capsule or spray form; dietary supplements in powder, tablet, liquid, capsule or spray form; food supplements providing a source of vitamins and minerals and essential fatty acids and probiotic cultures in powder, tablet, liquid, capsule or spray form; nutritional supplements for human consumption providing a source of vitamins and minerals and essential fatty acids and probiotic cultures in powder, tablet, liquid, capsule or spray form; herbal supplements for general health and well-being, namely, in powder, tablet, liquid, capsule or spray form; nutritional supplements, namely, probiotic compositions in the nature of a vaginal probiotic for the treatment and prevention of bacterial and fungal vaginal infection; nutraceuticals for the treatment and prevention of bacterial vaginosis, vaginal discharge and odors, for preventing the growth of undesirable micro-organisms that can cause vaginal discharge and odor, killing bacteria that cause bacterial vaginosis, and for maintaining a desirable microflora in the vaginal cavity; micro-organisms culture for medical use, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and crohn's disease in which inflammation is present both in the small intestine and in the colon; pharmaceutical products containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and crohn's disease in which inflammation is present both in the small intestine and in the colon; pharmaceutical products, namely, probiotic lactic acid bacteria, probiotic bifidobacteria which are able to ferment and use the fibres in the human organism for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and crohn's disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements containing microorganisms and cultures of microorganisms, namely, probiotic lactic acid bacteria, probiotic bifidobacteria which are able to ferment and use the fibres in the human organism; pharmaceutical products for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and crohn's disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans; microbial and biological preparations for medical use for improving the physical well-being of humans, namely, reducing inflammation and pain; dietary supplements for medical use, and baby food, all the above containing preparations and products resulting from the processing of microorganisms, particularly metabolites obtained from the processing of probiotic bacterial cultures; probiotic and nutritional and dietary supplements; antifungal preparations; antifungal creams for medical use; vaginal antifungal preparations; fungal and bacterial probiotic supplements, and nutritional supplement for digestive health; nutritional supplement for combating digestive disorders such as Crohn's Disease, ulcerative colitis and irritable bowel syndrome

Trademark Events
Jul 31, 2023
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Feb 15, 2023
Automatic Update Of Assignment Of Ownership
Nov 22, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Nov 22, 2020
Teas Change Of Correspondence Received
Nov 22, 2020
Teas Withdrawal Of Attorney Received-Firm Retains
Nov 22, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 22, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 22, 2020
Teas Change Of Owner Address Received
Jan 30, 2019
Automatic Update Of Assignment Of Ownership
Jul 31, 2018
Registered-Principal Register
Jun 26, 2018
Notice Of Acceptance Of Statement Of Use E-Mailed
Jun 25, 2018
Allowed Principal Register - Sou Accepted
May 31, 2018
Statement Of Use Processing Complete
May 9, 2018
Use Amendment Filed
May 31, 2018
Case Assigned To Intent To Use Paralegal
May 9, 2018
Teas Statement Of Use Received
May 1, 2018
Noa E-Mailed - Sou Required From Applicant
Mar 6, 2018
Official Gazette Publication Confirmation E-Mailed
Mar 6, 2018
Published For Opposition
Feb 14, 2018
Notification Of Notice Of Publication E-Mailed
Jan 31, 2018
Approved For Pub - Principal Register
Nov 4, 2017
Notification Of Letter Of Suspension E-Mailed
Nov 4, 2017
Letter Of Suspension E-Mailed
Nov 4, 2017
Suspension Letter Written
Oct 17, 2017
Teas/Email Correspondence Entered
Oct 17, 2017
Correspondence Received In Law Office
Oct 16, 2017
Teas Response To Office Action Received
Sep 25, 2017
Notification Of Non-Final Action E-Mailed
Sep 25, 2017
Non-Final Action E-Mailed
Sep 25, 2017
Non-Final Action Written
Sep 25, 2017
Remove From Teasrf
Aug 30, 2017
Amendment From Applicant Entered
Aug 30, 2017
Correspondence Received In Law Office
Aug 28, 2017
Assigned To Lie
Aug 8, 2017
Paper Received
Jul 17, 2017
Notification Of Letter Of Suspension E-Mailed
Jul 17, 2017
Letter Of Suspension E-Mailed
Jul 17, 2017
Suspension Letter Written
Jun 21, 2017
Teas/Email Correspondence Entered
Jun 20, 2017
Correspondence Received In Law Office
Jun 20, 2017
Teas Response To Office Action Received
Mar 27, 2017
Notification Of Non-Final Action E-Mailed
Mar 27, 2017
Non-Final Action E-Mailed
Mar 27, 2017
Non-Final Action Written
Mar 21, 2017
Assigned To Examiner
Dec 28, 2016
New Application Office Supplied Data Entered

Trademark Alertz updated from USPTO on 2030-01-24